Emyria Limited
ASX:EMD.AX
Overview | Financials
Company Name | Emyria Limited |
Symbol | EMD.AX |
Currency | AUD |
Price | 0.03 |
Market Cap | 12,863,673 |
Dividend Yield | 0% |
52-week-range | 0.027 - 0.087 |
Industry | Health Information Services |
Sector | Healthcare |
CEO | Dr. Stewart James Washer B.Sc., BSc (Hons), Ph.D. |
Website | https://emyria.com |
An error occurred while fetching data.
About Emyria Limited
Emyria Limited, a clinical-stage biotech company, engages in the development of treatments for unmet medical needs. The company develops cannabinoid-based medicines, as well as MDMA drug discovery program. Its drug development program includes EMD-RX5 for treatment of psychological distress and irritable bowel syndrome; and EMD-RX7 for multiple medical conditions. The
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD